Demand For Unmet Medical Needs Bolsters the Global Multiple Sclerosis Drugs

Overview: Multiple sclerosis (MS) is a disease of the nervous system that affects the spinal cord and the brain. MS damages the myelin sheath, which surrounds and protects human...


Multiple sclerosis (MS) is a disease of the nervous system that affects the spinal cord and the brain. MS damages the myelin sheath, which surrounds and protects human nerve cells. This damage blocks the messages between the brain and the body, and leads to the symptoms of MS. The main symptoms of the disease includes problems of thinking and memory, vision problems, problems of coordination and balance, and muscle weakness. It affects women more than men and often occurs between 20 and 40 years of age.

Multiple sclerosis is divided mainly into four types. They are relapsing-remitting multiple sclerosis, progressive recurrent multiple sclerosis, progressive secondary multiple sclerosis, and primary progressive multiple sclerosis. Recurrent-remitting MS is the most common form of the disease, representing about 85% of the total number of cases of multiple sclerosis. Secondary progression is associated with the initial period of relapsing-remitting disease. About 50% of people with recurrent multiple sclerosis would present this form of the disease.

Browse report brief and TOC @

Drivers and Restraints:

In recent times, high unmet drug needs for the treatment of disease and large R & D channels have been among the major drivers of the global market for MS drugs. In addition, further research in the field of MS to develop innovative therapies has also led to the growth of the global market.  However, the expiry of patents on major drugs is a major limitation of the market for MS drugs. In addition, stricter regulatory hurdles are also hindering the growth of the market. Advances in biomedical science would create opportunities for the MS drugs. The increase in mergers and acquisitions between manufacturing companies and the rapid release of products are some of the main trends in the global multiple sclerosis drugs market.

Request free sample @

Geographic Segmentation:

On the basis of geography, Global Multiple Sclerosis Drugs Market is segmented into regions such as North America, Latin America, Europe, Middle East and Africa, and Asia Pacific. Europe region has a significant participation in the MS drug market. However, Asia Pacific is expected to publish high growth rates over the next five years in the global market. This is because many companies build their manufacturing and research facilities in the region. Developing regions have an advantage over developed regions due to low wages, the availability of a large group of talents, a less strict environment, health and safety standards. Japan, China and India are expected to be the fastest growing multiple sclerosis drugs markets in the Asia Pacific region.

Key Players in Global Multiple Sclerosis Drugs Market:

The key players in the Multiple Sclerosis Drugs Market are GlaxoSmithKline, Bayer, Novartis, Teva Pharmaceutical, Sanofi, Merck Serono, Abbvie, Pfizer, AB Science, Biogen Idec, and Opexa among others.

Inquire Before Buying @

Scope of the report:

The report offers a comprehensive analysis of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along this, the factors influential in effecting the market dynamics and trends are discussed in detail at the product level. Further, the performance of the market at the regional and country-level is assessed and the prospects with high growth potential are identified and debated.

The key players in the industry are profiled providing insights on their financial performance, market position and growth strategies. Comparative analysis on prime strategical activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry are provided. The report also offers a broad outlook of the market along with recommendations from industry experts on the opportunities for investment activity.

What else? Apart from the syndicated report, our in-house team has an expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions.

About Us:

Research Cosmos is a provider of standard and customized market research, business intelligence and consulting services across more than 100 domains in different industries of the world. We host the trending market reports of the world’s top-notch publishing companies, offering services to a wide range of customers from students to fortune 500 companies and discloses the hidden opportunities in every leading industry of the world.

Kevin Stewart
[email protected]
Global Sales Manager
Research Cosmos
+1 888 709 8757
LinkedIn –
Twitter –
Google+ –
Facebook –

No Comment

Leave a Reply